Teicoplanin
- TRADE NAMES: Targocid (Sanofi-Aventis); Tecoplanin; Teichomycin-A2
- INDICATIONS: Staphylococcal infections
- CLASS: Antibiotic, Antibiotic; glycopeptide, Antimicrobial
- HALF-LIFE: 150 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amikacin, Cephaloridine, Colistin, Gentamicin, Kanamycin, Neomycin, Streptomycin, Tobramycin, Vancomycin
PREGNANCY CATEGORY: N/A
Not recommended in pregnancy
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric